CorMedix (CRMD) Receives Second CRL from FDA for DefenCath
Go back to CorMedix (CRMD) Receives Second CRL from FDA for DefenCathCORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 5.29 -0.13 (2.4%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.42 | 52 Week High | $4.54 | |||
Open | $5.50 | 52 Week Low | $1.15 | |||
Day High | $6.22 | P/E | N/A | |||
Day Low | $5.13 | EPS | $-0.55 | |||
Volume | 1,777,843 |